FAQ/Help |
Calendar |
Search |
Today's Posts |
04-20-2017, 11:50 AM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
Moneyshow.com (registration) Adamas to Give Presentations on ADS-5102 as Treatment for Involuntary Muscle Movements Parkinson's News Today Adamas Pharmaceuticals will make two presentations in Boston this month on ADS-5102 as a treatment for involuntary muscle movements associated with Parkinson's disease. ADS-5102, a high-dose amantadine therapy, decreases the duration, intensity ... Adamas Targets Parkinson's and MSMoneyshow.com (registration) all 2 news articles » More... |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Involuntary movement any advice please? | Traumatic Brain Injury and Post Concussion Syndrome | |||
Involuntary movement during MRI? | Peripheral Neuropathy | |||
involuntary muscle movements(contraction, shaking) | Traumatic Brain Injury and Post Concussion Syndrome | |||
Adamas Provides Data Update On ADS-5102 - Controlled Release Amantadine | Parkinson's Disease |